A recent study in BMC Cancer delves into the prognostic implications of tumor multiplicity in intrahepatic cholangiocarcinoma (iCCA) after radical resection.
The study categorizes multifocal iCCA based on lesion count, highlighting three types: solitary tumors, two or three lesions in the same hepatic lobe, and more than three lesions in the same lobe.
Analysis of 354 iCCA patients revealed that multifocal tumors had worse survival outcomes than solitary tumors, with the number of hepatic lesions playing a critical role.
Patients with two or three lesions had survival rates comparable to solitary tumors, while those with more than three lesions fared significantly worse.
Higher tumor burden was associated with biological aggressiveness, impacting overall survival independently.
The study integrated findings with the AJCC staging system, showing nuances in survival outcomes based on lesion count in specific subgroups.
Lesion count demonstrated potential to refine risk stratification and influence treatment strategies, challenging traditional staging criteria.
The research suggests that radical surgery may benefit patients with type II multifocal tumors, while those with more than three lesions may require alternative therapies.
The study underscores an unmet clinical need in managing extensive multifocal iCCA and calls for personalized treatment approaches.
By considering lesion count in prognostic models and treatment algorithms, clinicians can optimize patient-centric care in multifocal iCCA.